Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mesothelioma, Malignant × rucaparib × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Small Cell Lung Carcinoma 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Primary Myelofibrosis 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia 1 Leiomyosarcoma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Carcinosarcoma 1 Adenocarcinoma of Lung 1

Interventions

Cisplatin 54 Pemetrexed 43 pembrolizumab 16 Nivolumab 14 Carboplatin 14 Gemcitabine 13 Cyclophosphamide 10 Radiotherapy 9 Drug Therapy 8 atezolizumab 7 Ipilimumab 7 durvalumab 6 Platinum 6 Doxorubicin 6 1,2-diaminocyclohexaneplatinum II citrate 6 tremelimumab 5 sodium thiosulfate 5 Vinorelbine 5 Radiotherapy, Intensity-Modulated 5 Chemotherapy, Adjuvant 5 Cerebral Decortication 5 sargramostim 4 defactinib 4 tumor necrosis factor-alpha, CNGRC fusion protein, human 3 Photochemotherapy 3 Neoadjuvant Therapy 3 Mitomycin 3 Interleukin-2 3 Dihematoporphyrin Ether 3 Decitabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03654833 2023-03-14

MiST

University of Leicester

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡